This hypothesis is consistent with previous findings showing that AKT inhibition in conjunction with ClQ treatment sensitizes non-stem glioma cells to apoptosis [69], an effect that has been explained by autophagy-related impacts of ClQ known to impair the fusion between autophagosomes and lysosomes [69]. The gene discussed is AKT1; the disease is glioma.